Earle Burgess is a Hematology physician affiliated with Levine Cancer Institute. OpenAlex indexes 110 publications with 3,768 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
Sponsor: Wake Forest University Health Sciences
- LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RegeneronProgram year202537 paymentsResearch$119,415openpaymentsdata.cms.gov ↗
- SeagenProgram year20256 paymentsResearch$49,765openpaymentsdata.cms.gov ↗
- PfizerProgram year202511 paymentsResearch$40,208openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Journal of Clinical Investigation
2024 - Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Journal of Clinical Investigation
2024 - Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Voorhees, MD
Levine Cancer Institute
Benjamin Moeller, MD, PhD
Levine Cancer Institute
Jubilee Brown, MD
Levine Cancer Institute
Robert Naumann, MD
Levine Cancer Institute
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”